<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/6083E7FB-0220-4F5F-97B0-7F6113B49A0C"><gtr:id>6083E7FB-0220-4F5F-97B0-7F6113B49A0C</gtr:id><gtr:name>MRC Unit, The Gambia</gtr:name><gtr:address><gtr:line1>MRC Laboratories, The Gambia</gtr:line1><gtr:line2>Atlantic Road PO Box 273</gtr:line2><gtr:line4>Fajara</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Gambia</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6083E7FB-0220-4F5F-97B0-7F6113B49A0C"><gtr:id>6083E7FB-0220-4F5F-97B0-7F6113B49A0C</gtr:id><gtr:name>MRC Unit, The Gambia</gtr:name><gtr:address><gtr:line1>MRC Laboratories, The Gambia</gtr:line1><gtr:line2>Atlantic Road PO Box 273</gtr:line2><gtr:line4>Fajara</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Gambia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/23D47341-B294-4027-B1ED-1C5C81B5B51E"><gtr:id>23D47341-B294-4027-B1ED-1C5C81B5B51E</gtr:id><gtr:firstName>Sarah</gtr:firstName><gtr:otherNames>Louise</gtr:otherNames><gtr:surname>Rowland-Jones</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U190085854"><gtr:id>FDF193DA-7DCC-4BDF-AE2C-0FED47C70974</gtr:id><gtr:title>The role of Nef in chronic immune activation and the pathogenesis on HIV-1 and HIV-2 infections</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U190085854</gtr:grantReference><gtr:abstractText>We are trying to understand why in general HIV-2 causes much less disease than HIV-1, even though some people with HIV-2 infection develop AIDS. We want to investigate whether there are important differences in one of the virus proteins called Nef between HIV-1 and HIV-2. We hypothesise that nef in HIV-2 is less likely to cause the immune system to over-react so-called immune activation so we are going to compare nef between HIV-1 and HIV-2, and between healthy people with HIV-2 and those with HIV-2 who have developed AIDS.</gtr:abstractText><gtr:technicalSummary>The CD4+ T cell decline in the symptomatic phase of HIV-1 infection is increasingly thought to be the result of the combined viral cytotoxicity and the chronic activation of the immune system. The viral protein Nef has been shown able to promote the activation of infected cells. The molecular mechanism of this effect of Nef is not yet fully understood, but Nef seems to increase the response of infected T cells to activation. HIV-2 infection leads to immunodeficiency with much longer asymptomatic phase and at a much lower frequency than HIV-1 infection. However, HIV-2 appears as cytopathogic as HIV-1. We propose to compare the contribution of HIV-1 and HIV-2 Nef proteins to immune activation. In this regard, we plan to construct plasmids bearing Nef allelic variants from proviral HIV and use them to measure the impact of the Nef variant proteins in T cell and macrophage activation and function (i.e. proliferative response, IL-2 and Th1 or Th2 cytokines release). The project would require the sequencing of nef proviral genes from several patients at different phase of disease, to allow the characterization of the most frequent alleles. Therefore in addition of the study of HIV-2 Nef function, this project would document HIV-2 proviral sequences variations in the Gambia.</gtr:technicalSummary><gtr:fund><gtr:end>2008-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-02-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>81036</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>Gambia, Republic of the</gtr:country><gtr:department>MRC Unit, The Gambia</gtr:department><gtr:description>MRC Gambia/MRC HIU collaboration on HIV-2 infection + infant immunology</gtr:description><gtr:id>5CE0BF78-4714-494B-AF6C-AFF61D4537D9</gtr:id><gtr:impact>All papers listed are joint outputs between MRC Gambia and MRC HIU/Nuffield department of Medicine in either HIV-2 or infant immunology.
Successful joint PhD completion for Dr SB in infant immunology. 2 joint HIV-2 PhDs completed.</gtr:impact><gtr:outcomeId>F915F3CBE85-1</gtr:outcomeId><gtr:partnerContribution>Intellectual partnership on HIV-2 research and infant immunology, logistical support for sample collection and epidemiological/clinical studies, laboratory facilities</gtr:partnerContribution><gtr:piContribution>Researchers from Oxford have participated in joint projects and have provided training for MRC Gambia staff.</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>Gambia, Republic of the</gtr:country><gtr:department>MRC Unit, The Gambia</gtr:department><gtr:description>Oxford/Gambia HIV-2 collaboration</gtr:description><gtr:id>2E1353F9-EDB4-46F8-8E5E-AE3BD067F321</gtr:id><gtr:impact>Several joint publications. Successful completion of jointly supervised PhDs for MRC Gambia staff (Dr CO, Dr LMY).</gtr:impact><gtr:outcomeId>hgvTiiJqFBA-1</gtr:outcomeId><gtr:partnerContribution>Provision of clinical and epidemiological data on long-term HIV-2 clinical and community cohorts, with sample bank. Access to selected samples for analysis. Hosting short-term visits of students and post-docs from our group in the Gambia, provision of access to laboratory facilities.</gtr:partnerContribution><gtr:piContribution>Training of local technicians and students in the Gambia and during visits to Oxford for specialist research techniques.</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>MRC Gambia Open days</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:id>4084A81E-33F1-4B4C-AB5C-2B4BDD5A0216</gtr:id><gtr:impact>open days for the public and study particpants with demonstrations, posters and short talks about the research work of the Unit

none</gtr:impact><gtr:outcomeId>2A251B46135</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006,2007,2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Joint MRC/Gambian government meeting on research ethics</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>75C554B8-2933-4890-98D1-E273A4899183</gtr:id><gtr:impact>Research ethics was discussed in a forum which included lay people, policy makers, clinicians and researchers.

None noted</gtr:impact><gtr:outcomeId>NhpPtWGLAK9</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>486559</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Strategic Grant</gtr:description><gtr:end>2012-01-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>1AC0A197-9124-4AE1-AB17-555AE9EDAB35</gtr:id><gtr:outcomeId>E3C26E12AFB0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-11-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>data on HIV-1 and HIV-2 sequences analysed in the Gambia have been added to the HIV database (Los Alamos) which is publicly available</gtr:description><gtr:id>AA73C5C8-4DCB-41D2-9F5C-31E606DD2094</gtr:id><gtr:impact>none</gtr:impact><gtr:outcomeId>MQWNo6Kz9z3</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>HIV sequences</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Full length functional envelope clones generated from HIV-2-infected patients from W. Africa, used for neutralising antibody and other functional studies.</gtr:description><gtr:id>AC08A0CA-BEBF-4F9A-838E-A05115CD6D1B</gtr:id><gtr:impact>Studies of the ability of HIV-2 envelopes to antagonise tetherin are underway in Stuart Neil's lab (GKT).</gtr:impact><gtr:outcomeId>RbGgsaEH86E</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>HIV-2 envelope clones</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>these are full-length HIV-2 envelope clones from W. African patients used in neutralising antibody assays and other functional studies</gtr:description><gtr:id>D746A158-CA53-4DE3-B8CD-7E641B2F2AFA</gtr:id><gtr:impact>work in progress in Stuart Neil's group for tetherin antagonism</gtr:impact><gtr:outcomeId>fYfzkaN3piJ</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>HIV-2 envelope clones</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Sequences generated from patient samples collected in China and W. Africa.</gtr:description><gtr:id>E270EEB1-EE03-485A-BF43-046F6E4D020B</gtr:id><gtr:impact>Sequences submitted to the HIV database in Los Alamos and now publicly available.</gtr:impact><gtr:outcomeId>fF88XoYNtNF</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>HIV-1 and HIV-2 sequences</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>BA288371-792E-4331-ADD1-8FD2FEF2887D</gtr:id><gtr:title>Two distinct epidemics: the rise of HIV-1 and decline of HIV-2 infection between 1990 and 2007 in rural Guinea-Bissau.</gtr:title><gtr:parentPublicationTitle>Journal of acquired immune deficiency syndromes (1999)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/51e1b118377280b8855a5294b9785d5c"><gtr:id>51e1b118377280b8855a5294b9785d5c</gtr:id><gtr:otherNames>Tienen Cv</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1525-4135</gtr:issn><gtr:outcomeId>85720150246</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>12928035-B5E7-46FF-B662-A90BC5A23AAF</gtr:id><gtr:title>Quality control assessment of human immunodeficiency virus type 2 (HIV-2) viral load quantification assays: results from an international collaboration on HIV-2 infection in 2006.</gtr:title><gtr:parentPublicationTitle>Journal of clinical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e4708c51d28a3a9f6819dd1e16bab69"><gtr:id>5e4708c51d28a3a9f6819dd1e16bab69</gtr:id><gtr:otherNames>Damond F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0095-1137</gtr:issn><gtr:outcomeId>4EABBF00837</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E8844EC7-E359-4B3B-8A10-C28F30A093D4</gtr:id><gtr:title>T-cell immunity to Kaposi sarcoma-associated herpesvirus: recognition of primary effusion lymphoma by LANA-specific CD4+ T cells.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f5dac7f19ae78980fe985938e68ca20"><gtr:id>8f5dac7f19ae78980fe985938e68ca20</gtr:id><gtr:otherNames>Sabbah S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>pm_15867_27_22234686</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED587D98-5A8C-4DB9-8741-A68428F504A6</gtr:id><gtr:title>Clinical predictors cannot replace biological predictors in HIV-2 infection in a community setting in West Africa.</gtr:title><gtr:parentPublicationTitle>International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b24ec7623b969cce808560f0704b0bbf"><gtr:id>b24ec7623b969cce808560f0704b0bbf</gtr:id><gtr:otherNames>Gourlay AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1201-9712</gtr:issn><gtr:outcomeId>pm_15867_27_22387142</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>295C6DAD-A039-4DFD-85E1-802B5FC90FF8</gtr:id><gtr:title>Minimal Sex-Differential Modulation of Reactivity to Pathogens and Toll-Like Receptor Ligands following Infant Bacillus Calmette-Gu&amp;eacute;rin Russia Vaccination.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8951bd2e3cc1e79b67eaed679998ac9"><gtr:id>a8951bd2e3cc1e79b67eaed679998ac9</gtr:id><gtr:otherNames>Darboe F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn><gtr:outcomeId>5aaa4b36f346b3.66090305</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E45D3052-89B1-4838-9E5B-F5B3C2986561</gtr:id><gtr:title>Antiretroviral Therapy for HIV-2 Infection: Recommendations for Management in Low-Resource Settings.</gtr:title><gtr:parentPublicationTitle>AIDS research and treatment</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8c306d45a1a18041c07012c2e6ffbf28"><gtr:id>8c306d45a1a18041c07012c2e6ffbf28</gtr:id><gtr:otherNames>Peterson K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>2090-1240</gtr:issn><gtr:outcomeId>ewJq4JpgcBw</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>07E6D1F1-DE7C-4D9E-925D-EE321C24A3A5</gtr:id><gtr:title>Direct relationship between virus load and systemic immune activation in HIV-2 infection.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c0ae9c03e19152fa146debeb3e0a9814"><gtr:id>c0ae9c03e19152fa146debeb3e0a9814</gtr:id><gtr:otherNames>Leligdowicz A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>E2DCE3A8ED8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D606C28F-083C-4F15-989C-E9C5BEC8918E</gtr:id><gtr:title>Undetectable plasma viral load predicts normal survival in HIV-2-infected people in a West African village.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d88cb86deecd8faeb7ee3b8ddbd7278c"><gtr:id>d88cb86deecd8faeb7ee3b8ddbd7278c</gtr:id><gtr:otherNames>van der Loeff MF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn><gtr:outcomeId>bTZg2tb29f7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D21F1C67-FF12-4A63-8EE0-F34CBBEBA630</gtr:id><gtr:title>CD4(+) T cell responses to cytomegalovirus in early life: a prospective birth cohort study.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ae8482b978a1b49a9fb521ff3168471"><gtr:id>2ae8482b978a1b49a9fb521ff3168471</gtr:id><gtr:otherNames>Miles DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>0D16446A9E8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5790FA34-9A9F-497F-93A9-ACAA0CC29A39</gtr:id><gtr:title>Predicting the extinction of HIV-2 in rural Guinea-Bissau.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4733c7e44c2264f342e6713e0e09b0be"><gtr:id>4733c7e44c2264f342e6713e0e09b0be</gtr:id><gtr:otherNames>Fryer HR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>56e151f2133c64.53474561</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>584C9654-E790-4646-A72A-060FBDF274EF</gtr:id><gtr:title>Effects of antenatal and postnatal environments on CD4 T-cell responses to Mycobacterium bovis BCG in healthy infants in the Gambia.</gtr:title><gtr:parentPublicationTitle>Clinical and vaccine immunology : CVI</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ae8482b978a1b49a9fb521ff3168471"><gtr:id>2ae8482b978a1b49a9fb521ff3168471</gtr:id><gtr:otherNames>Miles DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1556-679X</gtr:issn><gtr:outcomeId>10BDEB972F6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>18D3207C-BA28-4CE5-8A0B-2A6C5D2875A6</gtr:id><gtr:title>Mortality and immunovirological outcomes on antiretroviral therapy in HIV-1 and HIV-2-infected individuals in the Gambia.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f4aab35f65c58e64f6df1af9bd93169d"><gtr:id>f4aab35f65c58e64f6df1af9bd93169d</gtr:id><gtr:otherNames>Peterson I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>deortzSRmyH</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>481C99A7-3134-4829-878B-11ABD1210AEB</gtr:id><gtr:title>Placental malaria is associated with reduced early life weight development of affected children independent of low birth weight.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4cf7aeecb86e6d6e050116bf1a6bc7a8"><gtr:id>4cf7aeecb86e6d6e050116bf1a6bc7a8</gtr:id><gtr:otherNames>Walther B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>sXXUXj7TvWK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>072806DE-7DA8-488D-B685-CF6A2FBF7C86</gtr:id><gtr:title>Natural killer cell function is well preserved in asymptomatic human immunodeficiency virus type 2 (HIV-2) infection but similar to that of HIV-1 infection when CD4 T-cell counts fall.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/665d17a793c5b72eb49a1e5abaa3d19e"><gtr:id>665d17a793c5b72eb49a1e5abaa3d19e</gtr:id><gtr:otherNames>Nuvor SV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>066C6F82473</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>822022F4-9CE4-41BE-AC9B-98ECF2A0E344</gtr:id><gtr:title>Polyfunctional CD4(+) and CD8(+) T cell responses to tuberculosis antigens in HIV-1-infected patients before and after anti-retroviral treatment.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c721e059d2551533a2a9aa5e0ffde77b"><gtr:id>c721e059d2551533a2a9aa5e0ffde77b</gtr:id><gtr:otherNames>Sutherland JS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>kPAKGzXmz6M</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>901D3ADF-9852-481B-9DE6-5174D678FC90</gtr:id><gtr:title>Efficient Nef-mediated downmodulation of TCR-CD3 and CD28 is associated with high CD4+ T cell counts in viremic HIV-2 infection.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bce4ae0645d9057f268484bd9f35fa14"><gtr:id>bce4ae0645d9057f268484bd9f35fa14</gtr:id><gtr:otherNames>Khalid M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>pm_15867_27_22345473</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>15292346-AE88-415D-9B73-32006E2A0965</gtr:id><gtr:title>The effect of placental malaria infection on cord blood and maternal immunoregulatory responses at birth.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e16dca02a00616648b5fb16d77916ef0"><gtr:id>e16dca02a00616648b5fb16d77916ef0</gtr:id><gtr:otherNames>Flanagan KL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>NS1DJtSNcv1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>111C2E17-0686-43AD-9049-11EDA8E9B71E</gtr:id><gtr:title>Virological and immunological response to Combivir and emergence of drug resistance mutations in a cohort of HIV-2 patients in The Gambia.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7ecf15dad4439b15c78ef2845f4adcd3"><gtr:id>7ecf15dad4439b15c78ef2845f4adcd3</gtr:id><gtr:otherNames>Jallow S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>BC90491F4FF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DFEE0F89-4A2C-4DB2-A9AB-C33283110CBA</gtr:id><gtr:title>Sex-Differential Non-Vaccine-Specific Immunological Effects of Diphtheria-Tetanus-Pertussis and Measles Vaccination.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f0d00d6e320109e2364260747ad667c"><gtr:id>5f0d00d6e320109e2364260747ad667c</gtr:id><gtr:otherNames>Noho-Konteh F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>58c9679ce45591.60204073</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0BB7DBA2-CD71-42C5-A139-AD4EC0A9F853</gtr:id><gtr:title>Mycobacterial T cell responses in HIV-infected patients with advanced immunosuppression.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f7dade8ac247a685e3a355d13ad829c"><gtr:id>9f7dade8ac247a685e3a355d13ad829c</gtr:id><gtr:otherNames>Hammond AS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>2CB4260D644</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>625352A6-0086-46E3-A5CB-81EF156503D0</gtr:id><gtr:title>KIR content genotypes associate with carriage of hepatitis B surface antigen, e antigen and HBV viral load in Gambians.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bff4ee4ff81e130304b8d75404a55387"><gtr:id>bff4ee4ff81e130304b8d75404a55387</gtr:id><gtr:otherNames>Yindom LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5aaa4b372ab9e7.80868867</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B18CFBB-F602-4BCD-A0B8-D3C6AF6B572B</gtr:id><gtr:title>Genome-wide profiling of humoral immunity and pathogen genes under selection identifies immune evasion tactics of Chlamydia trachomatis during ocular infection.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c6521669de4b42f6ae98dc3d972d2fd"><gtr:id>0c6521669de4b42f6ae98dc3d972d2fd</gtr:id><gtr:otherNames>Pickering H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5aaa4b3647cab0.98896427</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F3E004A-0CF9-494B-8EB9-CC11F840D81D</gtr:id><gtr:title>Application of a novel, rapid, and sensitive oligonucleotide ligation assay for detection of cancer-predicting mutations in the precore and basal core promoter of hepatitis B virus.</gtr:title><gtr:parentPublicationTitle>Journal of clinical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e4312437420f8d76a925048cdb000f56"><gtr:id>e4312437420f8d76a925048cdb000f56</gtr:id><gtr:otherNames>Mendy ME</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0095-1137</gtr:issn><gtr:outcomeId>116C464D7D3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>159908F1-3374-4F97-8FD0-1CE41D5EFFF4</gtr:id><gtr:title>Downregulation of the T-cell receptor by human immunodeficiency virus type 2 Nef does not protect against disease progression.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/454abd45acde87969c2971d70129f029"><gtr:id>454abd45acde87969c2971d70129f029</gtr:id><gtr:otherNames>Feldmann J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>F0FE438CAC3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A092F478-1492-4BFC-9877-F8253D86AF3D</gtr:id><gtr:title>Immunogenicity of the tuberculosis vaccine MVA85A is reduced by coadministration with EPI vaccines in a randomized controlled trial in Gambian infants.</gtr:title><gtr:parentPublicationTitle>Science translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bbd9cb794d60ad6017c8b7d55cbd8f5d"><gtr:id>bbd9cb794d60ad6017c8b7d55cbd8f5d</gtr:id><gtr:otherNames>Ota MO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1946-6234</gtr:issn><gtr:outcomeId>Ms3KPqxn3mM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C17F2CFD-6D91-4B57-BAAB-021CC074749D</gtr:id><gtr:title>HLA-associated polymorphisms in the HIV-2 capsid highlight key differences between HIV-1 and HIV-2 immune adaptation.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c7219e699c28c45d6e339476809f7f10"><gtr:id>c7219e699c28c45d6e339476809f7f10</gtr:id><gtr:otherNames>de Silva TI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>5aaa4b37a5f727.10811010</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5ED4A5A4-4997-4FED-A77B-836414D44BD2</gtr:id><gtr:title>The tuberculin skin test (TST) is affected by recent BCG vaccination but not by exposure to non-tuberculosis mycobacteria (NTM) during early life.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/66a5780653887989616b1c6ad11d85bc"><gtr:id>66a5780653887989616b1c6ad11d85bc</gtr:id><gtr:otherNames>Burl S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>YdUdFugDHAK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>265CDB8D-7B99-4C06-ABFB-F1EA59644379</gtr:id><gtr:title>Negative Correlation between Circulating CD4FOXP3CD127Regulatory T Cells and Subsequent Antibody Responses to Infant Measles Vaccine but Not Diphtheria-Tetanus-Pertussis Vaccine Implies a Regulatory Role.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/729ba36d5705e40f5e7c40bd94950457"><gtr:id>729ba36d5705e40f5e7c40bd94950457</gtr:id><gtr:otherNames>Ndure J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn><gtr:outcomeId>5aaa4b366ee960.51348030</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F3CE9E63-2E49-4CA1-A943-D9957E1C6438</gtr:id><gtr:title>Seroprevalence of hepatitis B and C virus in HIV-1 and HIV-2 infected Gambians.</gtr:title><gtr:parentPublicationTitle>Virology journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b38acf269ced6a2bb7898d972d0dc858"><gtr:id>b38acf269ced6a2bb7898d972d0dc858</gtr:id><gtr:otherNames>Jobarteh M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1743-422X</gtr:issn><gtr:outcomeId>osnRd6Wj9U7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A601D84-8B39-4BA2-8242-C7C9B9AD5622</gtr:id><gtr:title>Immune reconstitution inflammatory syndrome and the influence of T regulatory cells: a cohort study in The Gambia.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d1bd6f250b0486d8e2467c652215b64"><gtr:id>2d1bd6f250b0486d8e2467c652215b64</gtr:id><gtr:otherNames>Zaidi I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_15867_27_22745716</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>66A3D8BC-4CF0-453F-98F8-117BCA7297B6</gtr:id><gtr:title>HTLV-1 in rural Guinea-Bissau: prevalence, incidence and a continued association with HIV between 1990 and 2007.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e3bb178c459f02e14fcf720afb9e75e8"><gtr:id>e3bb178c459f02e14fcf720afb9e75e8</gtr:id><gtr:otherNames>van Tienen C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn><gtr:outcomeId>dBYUJPoMoLx</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06A5A678-706A-4B1B-8B2C-08121DDF19FA</gtr:id><gtr:title>Cytomegalovirus infection in Gambian infants leads to profound CD8 T-cell differentiation.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ae8482b978a1b49a9fb521ff3168471"><gtr:id>2ae8482b978a1b49a9fb521ff3168471</gtr:id><gtr:otherNames>Miles DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>A5458D85288</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FE2A3649-0935-4F73-B1EB-F2AB219BC498</gtr:id><gtr:title>Delaying bacillus Calmette-Gu&amp;eacute;rin vaccination from birth to 4 1/2 months of age reduces postvaccination Th1 and IL-17 responses but leads to comparable mycobacterial responses at 9 months of age.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/66a5780653887989616b1c6ad11d85bc"><gtr:id>66a5780653887989616b1c6ad11d85bc</gtr:id><gtr:otherNames>Burl S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>tJ3P2yZEh8r</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CC7BDA26-41A0-4719-848B-A540DF40FCB5</gtr:id><gtr:title>Risk factors for and clinical outcome of congenital cytomegalovirus infection in a peri-urban West-African birth cohort.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8adf13cea6bd0d317f7b78f78d9b9906"><gtr:id>8adf13cea6bd0d317f7b78f78d9b9906</gtr:id><gtr:otherNames>van der Sande MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>F7D929E6D02</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4076BF93-2CC9-4C70-9F16-10A514C17785</gtr:id><gtr:title>Are plasma biomarkers of immune activation predictive of HIV progression: a longitudinal comparison and analyses in HIV-1 and HIV-2 infections?</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7d4bec89b63675f4ca163786a7f26441"><gtr:id>7d4bec89b63675f4ca163786a7f26441</gtr:id><gtr:otherNames>Nyamweya S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_15867_27_22970212</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>54F892AB-8701-4B56-892B-8E74565CFE75</gtr:id><gtr:title>Virological and immunological correlates of mother-to-child transmission of cytomegalovirus in The Gambia.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd643fc4f7e0057d277b9b11facd2c3d"><gtr:id>bd643fc4f7e0057d277b9b11facd2c3d</gtr:id><gtr:otherNames>Kaye S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>58AB96E1BD6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0666A6E6-2394-4E0F-9554-397427AD6F06</gtr:id><gtr:title>Development and evaluation of an oligonucleotide ligation assay for detection of drug resistance-associated mutations in the human immunodeficiency virus type 2 pol gene.</gtr:title><gtr:parentPublicationTitle>Journal of clinical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7ecf15dad4439b15c78ef2845f4adcd3"><gtr:id>7ecf15dad4439b15c78ef2845f4adcd3</gtr:id><gtr:otherNames>Jallow S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0095-1137</gtr:issn><gtr:outcomeId>EB945972846</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED73961D-0E7A-4A34-BF05-15A60DF78217</gtr:id><gtr:title>An underestimated lentivirus model: what can HIV-2 research contribute to the development of an effective HIV-1 vaccine?</gtr:title><gtr:parentPublicationTitle>Expert review of anti-infective therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/545a8f1a39a38eb2fb8b01eef51449af"><gtr:id>545a8f1a39a38eb2fb8b01eef51449af</gtr:id><gtr:otherNames>Hodges-Mameletzis I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1478-7210</gtr:issn><gtr:outcomeId>nfGV1PAvnCq</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60886B2C-F22E-4236-B610-A62E7A1C0CDB</gtr:id><gtr:title>Maintenance of large subpopulations of differentiated CD8 T-cells two years after cytomegalovirus infection in Gambian infants.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ae8482b978a1b49a9fb521ff3168471"><gtr:id>2ae8482b978a1b49a9fb521ff3168471</gtr:id><gtr:otherNames>Miles DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>F90AF81F735</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U190085854</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>